Meda in €2.3bn Rottapharm acquisition
This article was originally published in Scrip
Executive Summary
Rottapharm of Italy, which at the start of July was planning an initial public offering (IPO) by month-end, is to be acquired by Sweden's Meda for SEK21.2bn (€2.275bn).